Skip to content
DraconiticResearch
Search Sources API
201,683 studies31 sourcesUpdated just now
Peer-reviewedLicence not statedFuture Oncology

Combined halp and GRIm scores for risk stratification in metastatic pancreatic ductal adenocarcinoma

  1. 1Department of Medical Oncology, Ankara Bilkent City Hospital, Ankara, Türkiye

Related

  1. Exceptionally Durable Response to First-Line S-1 Monotherapy in Metastatic Pancreatic Adenocarcinoma: A Case Report
    Takayuki Ota, Shoji Iinuma, Yosuke Suyama
    CureusPeer-reviewedCC BYFull textGeneral medicineEurope PMC
  2. Non-Invasive Assessment of SMAD4 Expression Status in Pancreatic Ductal Adenocarcinoma: Diagnostic Value of T1ρ-Weighted Imaging Combined with Clinical Parameters
    Ke Li, Rui Guo, Jing Li +5
    Diagnostics (Basel, Switzerland)Peer-reviewedCC BYFull textGeneral medicineEurope PMC
  3. Polygenic scores for risk of pancreatic ductal adenocarcinoma: evaluation of novel and published models
    Samuel O. Antwi, Brandon J. Coombes, Erin E. Carlson +250
    npj Precision OncologyPeer-reviewedCC BY 4.0Full textOncologyHAL
  4. Surufatinib and camrelizumab plus nab-paclitaxel–gemcitabine as first-line treatment for metastatic pancreatic ductal adenocarcinoma: a retrospective cohort study
    Yudong Yuan, Dongdong Zhang, Yuying Li +1
    Frontiers in PharmacologyPeer-reviewedCC BY 4.0Pharmacology & toxicologyFrontiersCrossref
  5. Staging laparoscopy for radiographically non-metastatic pancreatic ductal adenocarcinoma: cytology-driven upstaging and the SENDAI-SL risk-enrichment score
    Daisuke Douchi, Shingo Yoshimachi, Naoki Rikiyama +13
    BJS OpenPeer-reviewedCC BY 4.0Full textOncologyPMC
BibTeX
@article{yesilyurt2026combined,
  title = {{Combined halp and GRIm scores for risk stratification in metastatic pancreatic ductal adenocarcinoma}},
  author = {Berkay Yeşilyurt and Ismet Seven and Fahriye Tuğba Köş},
  journal = {Future Oncology},
  year = {2026},
  month = sep,
  doi = {10.1080/14796694.2026.2732589},
  url = {https://doi.org/10.1080/14796694.2026.2732589},
}
RIS
TY  - JOUR
TI  - Combined halp and GRIm scores for risk stratification in metastatic pancreatic ductal adenocarcinoma
AU  - Berkay Yeşilyurt
AU  - Ismet Seven
AU  - Fahriye Tuğba Köş
PY  - 2026
DA  - 2026/09/12
JO  - Future Oncology
DO  - 10.1080/14796694.2026.2732589
UR  - https://doi.org/10.1080/14796694.2026.2732589
SN  - 1479-6694
SN  - 1744-8301
ER  -